Proteases as Targets for Therapy by Klaus, von der HelmProteases as Targets for Therapy by Klaus, von der Helm

Proteases as Targets for Therapy

byKlaus, von der HelmEditorBruce D. Korant, John C. Cheronis

Paperback | October 10, 2012

Pricing and Purchase Info

$193.34 online 
$220.95 list price save 12%
Earn 967 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


This volume is the first to combine latest information on viral, microbial and cellular proteolytic enzymes as potential targets for human therapeutics. Proteases control a large array of physiological reactions, and are involved in a variety of pathological processes for which effective medications are currently needed and/or being sought after. Although protease inhibitors have been investigated for many years, few have been employed therapeutically. Recent break- through by HIV protease inhibitors as therapeutic drugs has re-encouraged the search for inhibitors of other proteolytic enzymes. Klaus von der Helm, who described the first viral protease has brought leading experts together to discuss not only the success and problems of clinical use and continuing prospects, but to review further potential drug targets. This volume provides detailed information and evaluations of key viral, bacterial, fungal, and cellular proteases as potential future drug candidates.
Title:Proteases as Targets for TherapyFormat:PaperbackDimensions:410 pages, 23.5 × 15.5 × 0.02 inPublished:October 10, 2012Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642630235

ISBN - 13:9783642630231

Look for similar items by category:


Table of Contents

I: HIV Protease Inhibitors (PI).- II: Other Viral (Non-HIV) Protease Inhibitors.- III: (Non-Viral) Proteases Involved in Diseases.